Clinical trial demonstrates that rilonacept significantly reduces gout flares

Drug appears to be well tolerated by patients

2012-01-05

(Press-News.org) A phase II clinical trial found that rilonacept, an inhibitor of the protein interleukin-1 (IL-1), significantly reduced acute gout flares that occur when initiating uric acid-lowering therapy. Results of the trial—the first placebo-controlled study investigating IL-1 targeted therapy in prevention of gout flares—show rilonacept to be generally well tolerated with no serious infections or treatment-related serious adverse events reported. Full findings are published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).

Patients with gout—a type of inflammatory arthritis caused by the crystallization of urates in soft tissues—experience severe pain and swelling, often affecting the feet. A recent study also published in Arthritis & Rheumatism reported that doctor-diagnosed gout has risen over the past twenty years and now affects 8.3 million individuals in the U.S. Previous research shows that while gout attacks typically resolve spontaneously over several days, urate crystals remain in the joint, which can lead to recurrent attacks and if left untreated may permanently damage joints.

"To reduce deposits of crystals in the joints, we advise patients to initiate treatment with medications that lower levels of uric acid in the blood," said lead investigator Dr. H. Ralph Schumacher, Jr., Professor of Medicine at the University of Pennsylvania School of Medicine. The authors explain that in the early months of urate-lowering therapy, as crystal deposits are broken up, patients may experience gout attacks that are proposed to be due to the release of crystals from softened deposits. These urate crystals interact with cells that release interleukin-1 (IL-1) which can lead to a cascade of inflammation and acute joint pain flares.

Previous research has found that acute gout attacks brought on by uric acid-lowering therapy may make patients less likely to continue treatment. "Well tolerated drugs that reduce the risk of gout flares when initiating uric-acid lowering therapy could make patients more likely to continue important long-term treatments that control gout," added Dr. Schumacher.

Rilonacept—marketed under the brand name ARCALYST® to treat another disease—is designed to neutralize the protein IL-1 before it produces signals that can trigger inflammation. Thus, researchers looked to test the effectiveness of rilonacept in preventing gout flares and enrolled 83 patients at 27 study centers across the U.S. for a phase II clinical trial. Participants were 18 years of age or older and had gout, including a history of two or more gout flares within the prior year, as well as elevated blood levels of uric acid. Participants were randomized in a double blind fashion, with 41 administered rilonacept via subcutaneous injection (a double dose [320 mg], followed by (160 mg weekly for 16 weeks) and 42 administered weekly placebo. All patients were started on allopurinol (300mg/day) to reduce uric acid levels.

Trial results revealed a significantly lower number of gout flares in participants taking rilonacept with only 6 flares in the rilonacept arm compared with 33 in the placebo group. Researchers also observed fewer flares in patients treated with rilonacept as early as four weeks following the start of therapy. At the 12-week study point, only 15% of patients taking rilonacept had experienced gout flares compared to 45% of those in the placebo group. No deaths or serious infections occurred in either group. Common adverse events included infections reported in 15% of the rilonacept group compared with 26% with the placebo.

"This trial provides well-controlled evidence that this IL-1 blocker is effective in preventing acute gout flares in this setting," confirmed Dr. Schumacher. "Rilonacept appears safe and well tolerated and could increase patient adherence to long-term urate-lowering therapy." The authors recommend further evaluation of rilonacept in patients with gout.

### This study is published in Arthritis & Rheumatism. Media wishing to receive a PDF of the article may contact healthnews@wiley.com.

Full citation: "Rilonacept (IL-1 Trap) in the Prevention of Acute Gout Flares During Initiation of Urate-Lowering Therapy: Results of a Phase 2 Clinical Trial." H. R. Schumacher, Jr., John S. Sundy, Robert Terkeltaub, Howard R. Knapp, Scott J. Mellis, Neil Stahl, George D. Yancopoulos, Yuhwen Soo, Shirletta King-Davis, Steven P. Weinstein, Allen R. Radin on behalf of the 0619 Study Group. Arthritis & Rheumatism; Published Online: January 5, 2012 (DOI: 10.1002/art.33412). http://doi.wiley.com/10.1002/art.33412.

Author Contact: To arrange an interview with Dr. Schumacher, please contact Kim Menard with the Perelman School of Medicine, University of Pennsylvania Health System at kim.menard@uphs.upenn.edu or 215-662-6183.

About the Journal Arthritis & Rheumatism is an official journal of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), a division of the College, and covers all aspects of inflammatory disease. The American College of Rheumatology (http://www.rheumatology.org) is the professional organization who share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. For details, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1529-0131.

About Wiley-Blackwell Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit http://www.wileyblackwell.com or our new online platform, Wiley Online Library (http://www.wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.

ELSE PRESS RELEASES FROM THIS DATE:

New York's "Move Over" Laws Meant to Make Roadways Safer for Everyone

2012-01-05

Drivers might not be aware of two relatively new vehicle and traffic laws in New York that went into effect in the last year. The first law, found in New York State Vehicle and Traffic Law Article 1122-a, relates to bicyclists riding on the shoulder of a road. And the second law, Article 1144-a, relates to drivers and emergency vehicles stopped on the shoulder of a road. Being Mindful of Bicyclists Article 1122-a of New York State Vehicle and Traffic Law requires drivers approaching a bicyclist on the shoulder of the road to make an effort to put as much distance ...

Twin Cities light rail project presents both opportunities and risks for health, according to report

2012-01-05

WASHINGTON—The rezoning around a planned light rail line in the Twin Cities would create both opportunities and potential risks for the health of the people in the communities it would pass through, according to a health impact assessment (HIA) released today by PolicyLink, TakeAction Minnesota, and ISAIAH, a nonprofit coalition of 90 congregations of various faiths in the Minneapolis, St. Paul and St. Cloud region. The HIA was made possible through a grant by the Health Impact Project, which is a collaboration of the Robert Wood Johnson Foundation and The Pew Charitable ...

Fair Sentencing Act May Mean Early Release for Some With Crack Sentences

2012-01-05

In the 1980s, crack-cocaine use was seen as a problem of epic proportions. The conversion of powder cocaine to crack transformed what had been an expensive drug into a much cheaper, more widely available and -- in the beginning -- more potent drug. From the creation of a Cabinet-level Drug Czar to additional legislation from Congress, a variety of actions were demanded by the public to stop the perceived drug crime epidemic. Part of the response by Congress was increased penalties for crack-possession convictions, including mandatory minimum prison sentences that were ...

Pennsylvania Bans Texting While Driving

2012-01-05

Distracted driving is one of the most dangerous threats on our nation's roads. In 2009 alone, 5,474 people were killed and another 450,000 were injured at the hands of distracted drivers. Pennsylvania is by no means immune to this problem. Pittsburgh car accident lawyers witness firsthand the tragedies caused by drivers who fail to focus on the road. Thankfully, Pennsylvania will soon have a new tool in its arsenal to combat distracted driving -- starting March 8, 2012, texting while driving will be illegal across the state. Governor Tom Corbett signed the bill into ...

Tips to Avoid Premises Liability and Decorate Safely During the Holidays

2012-01-05

Ask any property owner and he will most likely tell you that owning property brings responsibility. Not only is an owner responsible for maintaining the property like mowing the lawn and shoveling the driveway during the winter months, they are also responsible for making sure the property is free and clear of dangerous conditions that could cause a person coming onto the property to be injured. If the property owner doesn't keep the property free from dangers and someone is injured, the owner could be legally responsible for the injuries under the theory of premises ...

The Dangers of Walking While Drunk

2012-01-05

The dangers of drunk driving in Florida are well-known. In 2009, the latest year for such statistics, more than 900 lives were lost in alcohol related car accidents. However, an increasing number of intoxicated pedestrians are being killed by oncoming cars. The National Highway Transportation Safety Administration (NHTSA) reported in 2008 that pedestrians are four times more likely to be killed if they are drunk compared to those who are sober. Across Florida, nearly a third of pedestrian deaths in 2010 involved a pedestrian who had been drinking. Reports indicate that ...

Reducing Tucson Bicycle Accidents Through Safety Awareness

2012-01-05

Tucson, Arizona is rated one of the top cities in the nation for bicycle commuting. In part due to the extensive network of bike paths and also Tucson's push to become a platinum-rated bike-friendly community, bicycle ridership increased 58 percent between 2009 and 2010. While the city as a whole has made great strides, there are a few pockets where bicycle safety needs an extra boost. The University of Arizona (UA) campus is one such pocket. With around 11,500 bicyclists on campus each day, the UA campus has the highest concentration of bicycles in the Tucson metro ...

Large Trucks: Accident Dangers and Safety Recommendations

2012-01-05

An 18-wheeler hit a bridge and overturned recently on Interstate 30 in Dallas, Texas. While no injuries were reported in the truck accident, the concern remains: 18-wheelers pose a threat to their drivers as well as other drivers and passengers on the road. And the larger the truck, the more deadly the accident outcome can be. According to the Federal Motor Carrier Safety Administration, 51,000 large truck accidents occurred in 2009, involving 74,000 people -- most of whom were in passenger vehicles. In those crashes, 2,987 people were killed. Unfortunately, Texas ...

"Never Events" in Hospitals Should Never Happen, But Should Be Reported

2012-01-05

When patients are injured or die accidentally during hospital stays, these incidents are rarely reported or publicized. Hospitals call these "never events," because they should never have occurred in the first place. While some of these adverse events may be inadvertent, many are caused by the negligent acts of hospital medical and staff personnel. The general public and future patients deserve to know the circumstances about how and why people were injured while hospitalized, so they can make informed decisions about their care. Never and Adverse Events Never ...

Efforts to Stop Loan Modification Scams Both in Illinois and Nationally

2012-01-05

The American economy still hasn't rebounded. Unemployment levels are hovering around ten percent, and the housing market is still slowly recovering from the housing crash of several years ago. Many homeowners are left looking for ways to make their mortgage payments and stay in their homes, including through loan modification. While there are many reputable companies that help people seek loan modifications, there are many more who are little more than "snake oil" salesman just trying to scam people out of their money and possibly their home. AOL Real Estate ...

Clinical trial demonstrates that rilonacept significantly reduces gout flares

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: